An error has been detected in the English version of the article «A guide for the administration of oral antineoplastic in patients with swallowing disorders», published in Farm Hosp. 2021;46(3):126-34:

In Table 1. Line 1 relative to ABIRATERONE film-coated tablets (Zytiga®).

Where it says:

The manufacturer recommends crushing or dissolving the product due to a potential decrease in efficacy.

Have to say:

The manufacturer no recommends crushing or dissolving the product due to a potential decrease in efficacy.